Biofrontera
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biofrontera generated cash of -$24,895,000, which is less than the previous year. Cash used in financing activities reached the amount of $8,411,000 last year. Net change in cash is therefore -$15,865,000.

Cash Flow

Biofrontera Inc. (NASDAQ:BFRIW): Cash Flow
2019 -37.67M 25.39M 16.4M
2020 -12.36M 0 13.19M
2021 -26.71M -11K 43.19M
2022 -16.19M -5.15M 14.02M
2023 -24.89M 619K 8.41M

BFRIW Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
17.40M24.74M8.27M7.45M3.33M
Operating activities
Net income
-20.13M-640K-37.71M-10.98M-10.98M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1.06M1.17M540K562K667K
Stock-based compensation expense
1.04M1.85M129K00
Deferred income tax benefit 1.04M1.85M129K00
Changes in operating assets and liabilities:
Accounts receivable, net
4.93M-70K-612K1.16M-757K
Inventories
-3.75M-2.81M2.59M2.97M-3.53M
Accounts payable
6.41M912K-773K-6.65M1.43M
Cash generated by operating activities
-24.89M-16.19M-26.71M-12.36M-37.67M
Investing activities
Purchases Of Investments
0-5.11M000
Investments In Property Plant And Equipment
-5K-38K-11K0-538K
Acquisitions Net
000025.93M
Cash generated by investing activities
619K-5.15M-11K025.39M
Financing activities
Common Stock Issued
4.50M9.39M29.93M00
Payments for dividends
00000
Repurchases of common stock
00000
Repayments of term debt
000-8.79M13.5M
Cash used in financing activities
8.41M14.02M43.19M13.19M16.4M
Net Change In Cash
-15.86M-7.33M16.46M825K4.11M
Cash at end of period
1.54M17.40M24.74M8.27M7.45M
Data sourceData sourceData source